Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity DrugCVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It's the latest example of limits imposed by insurance that disrupt treatments for patients.
Source: Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug (https://www.nytimes.com/2025/05/11/health/zepbound-wegovy-weight-loss-drugs.html)